New Targeted Treatments for Fragile X Syndrome

• Main Authors: Protic, Dragana, Salcedo-Arellano, Maria J, Dy, Jeanne Barbara, Potter, Laura A, Hagerman, Randi J
• Format: text
• Published: Archīum Ateneo 2019
• Subjects: Fragile X syndrome; acamprosate; cannabidiol; lovastatin; metformin; minocycline; sertraline; targeted treatment; Genetics and Genomics; Medicine and Health Sciences
• Online Access: https://archium.ateneo.edu/asmph-pubs/37; https://archium.ateneo.edu/cgi/viewcontent.cgi?article=1034&context=asmph-pubs
• Institution: Ateneo De Manila University

Fragile X Syndrome (FXS) is the most common cause of inherited intellectual disability with prevalence rates estimated to be 1:5,000 in males and 1:8,000 in females. The increase of >200 Cytosine Guanine Guanine (CGG) repeats in the 5' untranslated region of the Fragile X Mental Retardation...